ArticleACS medicinal chemistry letters2024
The New Frontier in Neurotherapeutics: From Brain Stimulation to Novel Psychotropics.
Article in ACS medicinal chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Highlight explores significant advancements in neuropharmacology and neurotechnology, emphasizing their transformative impact on treating psychological and neurological disorders. This publication covers recent patents that introduce novel tryptamine derivatives, entactogenic mindstate inducers, and psychoplastogens aimed at promoting neuronal growth. It discusses advanced brain monitoring and stimulation systems integrated with AI to optimize treatment protocols. These innovations represent substantial progress in crafting unique therapeutic approaches and diagnostic tools, heralding a new era of personalized and effective treatment strategies for complex mental health and neurological conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.